Watanabe, K.; Sato, E.; Mishima, E.; Moriya, S.; Sakabe, T.; Sato, A.; Fujiwara, M.; Fujimaru, T.; Ito, Y.; Taki, F.;
et al. Changes in Metabolomic Profiles Induced by Switching from an Erythropoiesis-Stimulating Agent to a Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor in Hemodialysis Patients: A Pilot Study. Int. J. Mol. Sci. 2023, 24, 12752.
https://doi.org/10.3390/ijms241612752
AMA Style
Watanabe K, Sato E, Mishima E, Moriya S, Sakabe T, Sato A, Fujiwara M, Fujimaru T, Ito Y, Taki F,
et al. Changes in Metabolomic Profiles Induced by Switching from an Erythropoiesis-Stimulating Agent to a Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor in Hemodialysis Patients: A Pilot Study. International Journal of Molecular Sciences. 2023; 24(16):12752.
https://doi.org/10.3390/ijms241612752
Chicago/Turabian Style
Watanabe, Kimio, Emiko Sato, Eikan Mishima, Shinobu Moriya, Takuma Sakabe, Atsuya Sato, Momoko Fujiwara, Takuya Fujimaru, Yugo Ito, Fumika Taki,
and et al. 2023. "Changes in Metabolomic Profiles Induced by Switching from an Erythropoiesis-Stimulating Agent to a Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor in Hemodialysis Patients: A Pilot Study" International Journal of Molecular Sciences 24, no. 16: 12752.
https://doi.org/10.3390/ijms241612752
APA Style
Watanabe, K., Sato, E., Mishima, E., Moriya, S., Sakabe, T., Sato, A., Fujiwara, M., Fujimaru, T., Ito, Y., Taki, F., Nagahama, M., Tanaka, K., Kazama, J. J., & Nakayama, M.
(2023). Changes in Metabolomic Profiles Induced by Switching from an Erythropoiesis-Stimulating Agent to a Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor in Hemodialysis Patients: A Pilot Study. International Journal of Molecular Sciences, 24(16), 12752.
https://doi.org/10.3390/ijms241612752
